Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Bioanalysis|August 3, 2017
Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technologyKathi Williams, Rich Erickson, Saloumeh Kadkhodayan FischerThe AAPS Journal|December 15, 2018
Measurement of IL-17AA and IL-17FF as Pharmacodynamic Biomarkers to Demonstrate Target Engagement in the Phase I Study of MCAF5352AKun Peng, Yehong Wang, Ketevan Siradze, et al.Journal of Clinical Pharmacology|November 28, 2017
Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative ColitisXiaohui Wei, Leonid Gibiansky, Yehong Wang, et al.Advances in Therapy|March 29, 2021
Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy VolunteersWenhui Zhang, Helen Tyrrell, Han Ting Ding, et al.Clinical Pharmacology and Therapeutics|June 29, 2018
Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial InjuryMichael E Rothenberg, Yehong Wang, Annemarie Lekkerkerker, et al.Bioanalysis|September 28, 2012
Utilizing design of experiments to characterize assay robustnessKyra J Cowan, Rich Erickson, Brian Sue, et al.Mabs|December 9, 2014
Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case studyKun Peng, Keyang Xu, Luna Liu, et al.The Journal of Pathology|April 1, 2009
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinomaLaura A Strickland, Jed Ross, Simon Williams, et al.Frontiers in Pharmacology|February 19, 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel DiseaseCharlotte Lichnog, Sha Klabunde, Emily Becker, et al.Science Translational Medicine|May 13, 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's diseaseGai Ayalon, Seung-Hye Lee, Oskar Adolfsson, et al.Pageof 1